Title : Overview of current and future systemic therapy for metastatic renal cell carcinoma.

Pub. Date : 2019 May 1

PMID : 30722031






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The first VEGF inhibitors approved for mRCC were sorafenib and sunitinib. Sorafenib vascular endothelial growth factor A Homo sapiens